Literature DB >> 1679277

Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta.

H J Schluesener1, R Meyermann.   

Abstract

The multidrug transporting cell membrane molecule P-glycoprotein can be spontaneously expressed in human glioma cells. Transcripts of mdr genes were detected in glial tumor cells by polymerase chain reaction and Northern blotting, expression of P-glycoprotein was analyzed by immunocytochemistry and functional activity by cytofluorometry of fluorescent probe transport. In vitro treatment of glioma cells with vincristine induced coordinate over-expression of both mdr1 and mdr3 genes associated with very high P-glycoprotein-mediated multidrug transport, resistant to the inhibitory activity of chemosensitizers like verapamil. The physiological modulators of multidrug transport are as yet unknown. We therefore initiated a screening program to analyze the effects of cytokines on multidrug transport. We observed, that transforming growth factors (TGF)-beta 1, -beta 2, and -beta 1.2-but not the related bone morphogenetic protein (BMP) 2--inhibited multidrug transport. Interestingly, BMP 2 antagonized the TGF-beta induced inhibition of multidrug transport.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679277     DOI: 10.1007/bf00296374

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  49 in total

1.  Genes amplified and overexpressed in human multidrug-resistant cell lines.

Authors:  A M Van der Bliek; F Baas; T Van der Velde-Koerts; J L Biedler; M B Meyers; R F Ozols; T C Hamilton; H Joenje; P Borst
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

2.  Multidrug resistance: molecular biology and clinical relevance.

Authors:  M Rothenberg; V Ling
Journal:  J Natl Cancer Inst       Date:  1989-06-21       Impact factor: 13.506

3.  Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells.

Authors:  M B Meyers; V J Merluzzi; B A Spengler; J L Biedler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  TGF-beta 1, beta 2, beta 1.2 and the bone morphogenetic protein BMP2: members of the transforming growth factor type beta supergene family with different morphogenetic effects on rat astrocyte cultures.

Authors:  H J Schluesener; R Meyermann
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

5.  Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance.

Authors:  H J Broxterman; H M Pinedo; C M Kuiper; J J van der Hoeven; P de Lange; J J Quak; R J Scheper; H G Keizer; G J Schuurhuis; J Lankelma
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

6.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

7.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

Authors:  C W Czarniecki; H H Chiu; G H Wong; S M McCabe; M A Palladino
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

8.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

Authors:  D W Shen; A Fojo; J E Chin; I B Roninson; N Richert; I Pastan; M M Gottesman
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

9.  Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

Authors:  I B Roninson; J E Chin; K G Choi; P Gros; D E Housman; A Fojo; D W Shen; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.

Authors:  R de Martin; B Haendler; R Hofer-Warbinek; H Gaugitsch; M Wrann; H Schlüsener; J M Seifert; S Bodmer; A Fontana; E Hofer
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  5 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  The multidrug-resistance gene MDR1 is expressed in human glial tumors.

Authors:  I Becker; K F Becker; R Meyermann; V Höllt
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 3.  Therapeutic implications of the TGF-beta system.

Authors:  B A Arrick
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

4.  Intercrines in brain pathology. Expression of intercrines in a multiple sclerosis and Morbus Creutzfeldt-Jakob lesion.

Authors:  H J Schluesener; R Meyermann
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Detection of two transforming growth factor-beta-related morphogens, bone morphogenetic proteins-4 and -5, in RNA of multiple sclerosis and Creutzfeldt-Jakob disease lesions.

Authors:  M Deininger; R Meyermann; H Schluesener
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.